stockrowIngevity Corporation
NGVT Basic Materials Specialty Chemicals
Ingevity Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, down 2.71% from fiscal 2024.
- Revenue
- −5.25%
- EPS
- +125.4%
- Free cash flow
- −136.1%
- Total debt
- −14.5%
Quarter to June 2026, against a year earlier
Follow NGVT
Alert me
Ingevity Corporation (NGVT) Shares outstanding
Ingevity Corporation's shares outstanding at the end of fiscal 2025 was $36.2M, unchanged from fiscal 2024. At the end of the quarter to 30 June 2026 it was $35.3M. Over the past ten years it has ranged from $36.2M (fiscal 2025) to $42.6M (fiscal 2018) — the current reading is the lowest in ten years. Ingevity Corporation ranks 39th of 59 Specialty Chemicals companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $36.2M | (0.28%) |
| FY2024 | $36.3M | (1.04%) |
| FY2023 | $36.7M | (4.59%) |
| FY2022 | $38.5M | (3.96%) |
| FY2021 | $40.1M | (3.58%) |
| FY2020 | $41.5M | (1.55%) |
| FY2019 | $42.2M | (0.94%) |
| FY2018 | $42.6M | 0.17% |
| FY2017 | $42.5M | 0.61% |
| FY2016 | $42.3M | 0.40% |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Jun 2026 | $35.3M | (2.05%) |
| Mar 2026 | $36.0M | (0.56%) |
| Dec 2025 | $36.2M | (1.98%) |
| Sep 2025 | $37.0M | 1.35% |
| 42 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| CC The Chemours Company compare | $151.9M |
| FUL H. B. Fuller Company compare | $54.9M |
| NGVT Ingevity Corporation | $35.3M |
| MTX Minerals Technologies Inc. compare | $31.2M |
| STDN Standard Nuclear Inc compare | $28.0M |
| IOSP Innospec Inc. compare | $24.7M |
| HWKN Hawkins, Inc. compare | $20.8M |
| KWR Quaker Houghton compare | $17.3M |
| WDFC WD-40 Company compare | $13.5M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on NGVT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement